Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
- PMID: 9306402
- DOI: 10.1038/nbt0997-871
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Abstract
Retroviral vectors derived from lentiviruses such as HIV-1 are promising tools for human gene therapy because they mediate the in vivo delivery and long-term expression of transgenes in nondividing tissues. We describe an HIV vector system in which the virulence genes env, vif, vpr, vpu, and nef have been deleted. This multiply attenuated vector conserved the ability to transduce growth-arrested cells and monocyte-derived macrophages in culture, and could efficiently deliver genes in vivo into adult neurons. These data demonstrate the potential of lentiviral vectors in human gene therapy.
Similar articles
-
An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.Virology. 2001 Mar 30;282(1):77-86. doi: 10.1006/viro.2000.0787. Virology. 2001. PMID: 11259192
-
Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.Gene Ther. 1999 May;6(5):715-28. doi: 10.1038/sj.gt.3300895. Gene Ther. 1999. PMID: 10505094
-
Hepatocyte-specific gene expression from integrated lentiviral vectors.J Gene Med. 2004 Sep;6(9):974-83. doi: 10.1002/jgm.591. J Gene Med. 2004. PMID: 15352070
-
Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo.FASEB J. 1997 Jul;11(8):624-34. doi: 10.1096/fasebj.11.8.9240964. FASEB J. 1997. PMID: 9240964 Review.
-
Use of herpes virus amplicon vectors to study brain disorders.Biotechniques. 2005 Sep;39(3):381-91. doi: 10.2144/05393PS01. Biotechniques. 2005. PMID: 16206910 Review.
Cited by
-
Investigation of Cell Mechanics and Migration on DDR2-Expressing Neuroblastoma Cell Line.Life (Basel). 2024 Oct 2;14(10):1260. doi: 10.3390/life14101260. Life (Basel). 2024. PMID: 39459560 Free PMC article.
-
Nanotechnology and CRISPR/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders.Mol Biotechnol. 2024 Oct 24. doi: 10.1007/s12033-024-01301-8. Online ahead of print. Mol Biotechnol. 2024. PMID: 39446301 Review.
-
Trends on Novel Targets and Nanotechnology-Based Drug Delivery System in the Treatment of Parkinson's disease: Recent Advancement in Drug Development.Curr Drug Targets. 2024;25(15):987-1011. doi: 10.2174/0113894501312703240826070530. Curr Drug Targets. 2024. PMID: 39313872 Review.
-
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants.NPJ Vaccines. 2024 Sep 9;9(1):164. doi: 10.1038/s41541-024-00950-9. NPJ Vaccines. 2024. PMID: 39251608 Free PMC article.
-
In vivo liver targeted genome editing as therapeutic approach: progresses and challenges.Front Genome Ed. 2024 Aug 23;6:1458037. doi: 10.3389/fgeed.2024.1458037. eCollection 2024. Front Genome Ed. 2024. PMID: 39246827 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical